Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma

BACKGROUND: Histological analysis has revealed the need for new treatment techniques for epithelial ovarian cancer. Immune checkpoint inhibitors may be a new therapeutic strategy for ovarian clear cell carcinoma (OCCC). Lymphocyte-activation gene 3 (LAG-3), an immune checkpoint, is a poor prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaitsu, Sumika, Yano, Mitsutake, Adachi, Sawako, Miwa, Maiko, Katoh, Tomomi, Kawano, Yasushi, Yasuda, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182671/
https://www.ncbi.nlm.nih.gov/pubmed/37179337
http://dx.doi.org/10.1186/s13048-023-01179-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182671/
https://www.ncbi.nlm.nih.gov/pubmed/37179337
http://dx.doi.org/10.1186/s13048-023-01179-1

Ejemplares similares